bioRxivBiochemistryPreprint
A conserved homo-dimerization interface in human IFIT1 provides insights into IFIT interactome assembly
Yazan M. AbbasiD, Saúl Martínez-Montero, Regina Cencic, Jerry PelletieriD, Peter D. Pawelek, Masad J. Damha, Bhushan NagariD
Abstract
The Interferon-Induced Proteins with Tetratricopeptide Repeats (IFITs) are a group of potently expressed Interferon Stimulated Genes that mediate antiviral innate immunity. Previous studies have revealed that most IFITs partake in higher order structures, potentially as part of an IFIT interactome that results in viral inhibition. Recent crystal structures of a mutated, monomeric form of IFIT1 revealed the molecular basis of how it recognizes non-self, capped viral mRNAs to selectively inhibit their translation. However, wild-type IFIT1 forms dimers in solution and the role of dimerization was not examined in detail. Here we present a structural and biochemical analysis of wild-type IFIT1 in complex with capped and uncapped RNA. Wild-type IFIT1 forms an antiparallel, elongated dimer that is in stark contrast to the domain-swapped, parallel dimer found in IFIT2. Dimerization takes place through a small, C-terminal interface that is evolutionarily conserved in IFIT1 and IFIT1B proteins. The interface is modular and can be grafted onto IFIT5, which is natively monomeric, to induce dimerization. Mutational analysis of this interface showed that homo-dimerization is not required for full RNA binding or translational inhibition by IFIT1. Sedimentation velocity analytical ultracentrifugation measurements demonstrated a reversible monomer-dimer equilibrium, suggesting that dimerization is of low affinity and could play a role under physiological concentrations, possibly in regulating IFIT interactome assembly. Finally, conformational changes in IFIT1 that occur upon RNA binding provide insight into how RNA enters its binding site in solution.
- organism: human
- assay: protein structure
- research focus: protein folding & dynamics
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA.
R. C. Fleith, H. V. Mears, … T. R. Sweeney·bioRxiv·Feb 8, 2018
- Cap-related modifications of RNA regulate binding to IFIT proteins
Jingping Geng, Magdalena Chrabąszczewska, … Renata Grzela·RNAPeer-reviewed·Jul 15, 2024
- An MST-based assay reveals new binding preferences of IFIT1 for canonically and non-canonically capped RNAs
Tomasz Śpiewla, Katarzyna Grab, … Joanna Kowalska·RNAPeer-reviewed·Dec 6, 2024
- IFIT3 controls IFIT1 accumulation and specificity preventing self mRNA targeting during the innate immune response.
Renata C. Fleith, Xin Yun Leong, … Trevor R. Sweeney·bioRxiv·Nov 17, 2025
- Short 5' UTRs serve as a marker for viral mRNA translation inhibition by the IFIT2-IFIT3 antiviral complex
Dustin R. Glasner, Candace Todd, … Matthew D. Daugherty·bioRxiv·Feb 11, 2025
- IFIT1 is rapidly evolving and exhibits disparate antiviral activities across 11 mammalian orders
Matthew B. McDougal, Ian N. Boys, … John W. Schoggins·eLifePeer-reviewed·Oct 22, 2025